• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1号染色体拷贝数变异在肝细胞癌中的作用

Role of chromosome 1q copy number variation in hepatocellular carcinoma.

作者信息

Jacobs Nathan R, Norton Pamela A

机构信息

Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, United States.

出版信息

World J Hepatol. 2021 Jun 27;13(6):662-672. doi: 10.4254/wjh.v13.i6.662.

DOI:10.4254/wjh.v13.i6.662
PMID:34239701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8239492/
Abstract

Chromosome 1q often has been observed to be amplified in hepatocellular carcinoma. This review summarizes literature reports of multiple genes that have been proposed as possible 1q amplification drivers. These largely fall within 1q21-1q23. In addition, publicly available copy number alteration data from The Cancer Genome Atlas project were used to identify additional candidate genes involved in carcinogenesis. The most frequent location for gene amplification was 1q22, consistent with the results of the literature search. The genes and were found to be candidates whose amplification and/or mRNA up-regulation was most highly associated with poorer hepatocellular carcinoma outcomes.

摘要

1号染色体长臂在肝细胞癌中常被观察到发生扩增。本综述总结了多篇文献报道中被认为可能是1号染色体长臂扩增驱动因素的多个基因。这些基因大多位于1q21 - 1q23区域。此外,利用来自癌症基因组图谱项目的公开拷贝数变异数据来识别参与致癌作用的其他候选基因。基因扩增最常见的位置是1q22,这与文献检索结果一致。发现基因 和 是其扩增和/或mRNA上调与肝细胞癌较差预后最密切相关的候选基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/8239492/3a27f2c387d0/WJH-13-662-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/8239492/c1b1df291bfc/WJH-13-662-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/8239492/3a27f2c387d0/WJH-13-662-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/8239492/c1b1df291bfc/WJH-13-662-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/8239492/3a27f2c387d0/WJH-13-662-g002.jpg

相似文献

1
Role of chromosome 1q copy number variation in hepatocellular carcinoma.1号染色体拷贝数变异在肝细胞癌中的作用
World J Hepatol. 2021 Jun 27;13(6):662-672. doi: 10.4254/wjh.v13.i6.662.
2
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.在乳腺癌中,1q21 和 1q32 的频繁拷贝数增益与 ETS 转录因子 ETV3 和 ELF3 的过度表达有关,而与分子亚型无关。
Breast Cancer Res Treat. 2013 Feb;138(1):37-45. doi: 10.1007/s10549-013-2408-2. Epub 2013 Jan 18.
3
Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.肝细胞癌中1q21 - q22上扩增DNA序列的定位图谱表明候选基因过表达。
J Hepatol. 2003 Mar;38(3):298-306. doi: 10.1016/s0168-8278(02)00412-9.
4
Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.通过对肝细胞癌进行比较基因组杂交和微卫星分析相结合,鉴定出1号染色体上四个不同的等位基因不平衡区域。
Mod Pathol. 2002 Nov;15(11):1213-20. doi: 10.1097/01.MP.0000036347.66943.3C.
5
[Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients].[1q21扩增对新诊断多发性骨髓瘤患者硼替佐米治疗反应及预后的影响]
Zhonghua Xue Ye Xue Za Zhi. 2018 May 14;39(5):408-413. doi: 10.3760/cma.j.issn.0253-2727.2018.05.013.
6
Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.使用 OncoScan 染色体拷贝数畸变数据预测早期肝细胞癌。
World J Gastroenterol. 2017 Nov 28;23(44):7818-7829. doi: 10.3748/wjg.v23.i44.7818.
7
Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.肝细胞癌中控制核心岩藻糖基化的基因表达:系统评价。
World J Gastroenterol. 2019 Jun 21;25(23):2947-2960. doi: 10.3748/wjg.v25.i23.2947.
8
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.乳腺癌中1号染色体的基因谱分析:1号染色体上增减区域的定位及1q上候选基因的鉴定
Br J Cancer. 2006 Nov 20;95(10):1439-47. doi: 10.1038/sj.bjc.6603433. Epub 2006 Oct 24.
9
Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis.通过半定量微卫星分析检测人肝细胞癌中1q染色体臂增益和1p染色体臂缺失的离散断点定位及最短重叠区域
Genes Chromosomes Cancer. 2005 Jan;42(1):34-43. doi: 10.1002/gcc.20117.
10
KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.KIAA1096基因位于1号染色体上,在膀胱癌中发生扩增并过度表达。
DNA Cell Biol. 2002 Oct;21(10):707-15. doi: 10.1089/104454902760599681.

引用本文的文献

1
NUCKS1 exacerbates hepatocellular carcinoma cell proliferation and metastasis via the upregulation of Cdc42.NUCKS1通过上调Cdc42加剧肝癌细胞的增殖和转移。
Am J Cancer Res. 2025 Mar 15;15(3):1051-1065. doi: 10.62347/IAMC6442. eCollection 2025.
2
Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.用于肝细胞癌预后分层分析的DNA损伤反应与修复相关基因对特征的鉴定
Front Pharmacol. 2022 Apr 5;13:857060. doi: 10.3389/fphar.2022.857060. eCollection 2022.

本文引用的文献

1
Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.NUF2 过表达与多种癌症患者生存预后较差相关。
Cancer Res Treat. 2021 Oct;53(4):944-961. doi: 10.4143/crt.2020.466. Epub 2020 Jan 4.
2
Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma.基于随机森林算法的生物标志物在预测肝细胞癌患者预后中的应用
Cancer Cell Int. 2020 Jun 17;20:251. doi: 10.1186/s12935-020-01274-z. eCollection 2020.
3
The Novel Transcription Factor CREB3L4 Contributes to the Progression of Human Breast Carcinoma.
新型转录因子 CREB3L4 促进人乳腺癌的进展。
J Mammary Gland Biol Neoplasia. 2020 Mar;25(1):37-50. doi: 10.1007/s10911-020-09443-6. Epub 2020 Feb 6.
4
Nuclear division cycle 80 complex is associated with malignancy and predicts poor survival of hepatocellular carcinoma.核分裂周期80复合体与恶性肿瘤相关,并预示肝细胞癌患者预后不良。
Int J Clin Exp Pathol. 2019 Apr 1;12(4):1233-1247. eCollection 2019.
5
HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.HN1L 介导的转录轴 AP-2γ/METTL13/TCF3-ZEB1 驱动肝细胞癌的肿瘤生长和转移。
Cell Death Differ. 2019 Nov;26(11):2268-2283. doi: 10.1038/s41418-019-0301-1. Epub 2019 Feb 18.
6
NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.核仁素 2 是一种有价值的预后生物标志物,可预测肝细胞癌切除术后的早期复发。
Int J Cancer. 2019 Aug 1;145(3):662-670. doi: 10.1002/ijc.32134. Epub 2019 Feb 4.
7
METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis.METTL13 通过甲基化 eEF1A 增加翻译产出以促进肿瘤发生。
Cell. 2019 Jan 24;176(3):491-504.e21. doi: 10.1016/j.cell.2018.11.038. Epub 2019 Jan 3.
8
Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.肝细胞癌的全球流行病学、预防与管理
Am Soc Clin Oncol Educ Book. 2018 May 23;38:262-279. doi: 10.1200/EDBK_200939.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.TCGA 泛癌临床数据资源整合,推动高质量生存预后分析。
Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.